Fund Holdings — Prosight Management, LP

Total Portfolio Value:
$394.35M
Total Bought:
$121.73M
Total Sold:
$64.10M
Net Transaction:
+$57.63M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ADC Therapeutics SASHS(ADCT)9,570,0009,636,237+66,237$30.24M$30.35M7.70%+$112.9K
Lakefront Biotherapeutics NVADR(LKFT)1,349,9801,028,843-321,137$33.45M$29.62M7.51%-$3.83M
BridgeBio Pharma, Inc.(BBIO)800,0001,086,810+286,810$20.26M$27.67M7.02%+$7.41M
AbCellera Biologics Inc.(ABCL)2,352,6339,079,539+6,726,906$6.96M$23.61M5.99%+$16.64M
MeiraGTx Holdings plc(MGTX)4,352,7004,900,570+547,870$18.32M$20.44M5.18%+$2.11M
Roivant Sciences Ltd.SHS(ROIV)2,000,0001,721,512-278,488$21.14M$19.87M5.04%-$1.27M
Shattuck Labs, Inc.(STTK)4,670,0005,678,726+1,008,726$18.03M$19.82M5.03%+$1.79M
Mirum Pharmaceuticals, Inc.(MIRM)314,800465,825+151,025$10.76M$18.17M4.61%+$7.40M
Zimmer Biomet Holdings, Inc.(ZBH)170,000165,602-4,398$18.45M$17.88M4.53%-$573.4K
McKesson Corporation(MCK)035,822+35,822$0$17.71M4.49%+$17.71M
Kura Oncology, Inc.(KURA)629,900705,109+75,209$12.97M$13.78M3.49%+$808.2K
Schrödinger, Inc.(SDGR)369,261700,000+330,739$7.14M$12.98M3.29%+$5.84M
Zymeworks Inc.(ZYME)1,180,000917,599-262,401$10.04M$11.52M2.92%+$1.47M
Accolade Inc1,489,5252,801,598+1,312,073$5.33M$10.79M2.74%+$5.45M
DexCom, Inc.(DXCM)49,317160,000+110,683$5.59M$10.73M2.72%+$5.13M
Syndax Pharmaceuticals, Inc.(SNDX)551,544554,103+2,559$11.32M$10.67M2.70%-$656.7K
Immunovant, Inc.(IMVT)325,000370,000+45,000$8.58M$10.55M2.67%+$1.97M
Cytokinetics, Incorporated(CYTK)230,000192,700-37,300$12.46M$10.17M2.58%-$2.29M
Janux Therapeutics, Inc.(JANX)0205,000+205,000$0$9.31M2.36%+$9.31M
Prothena Corp PlcSHS
SHS
286,926483,467+196,541$5.92M$8.09M2.05%+$2.17M
Neurocrine Biosciences, Inc.(NBIX)27,00062,000+35,000$3.72M$7.14M1.81%+$3.43M
Erasca, Inc.(ERAS)2,750,0001,984,010-765,990$6.49M$5.42M1.37%-$1.07M
Haemonetics Corporation(HAE)065,000+65,000$0$5.22M1.32%+$5.22M
LivaNova PLCSHS(LIVN)090,000+90,000$0$4.73M1.20%+$4.73M
Cogent Biosciences, Inc.(COGT)500,000410,830-89,170$4.21M$4.44M1.13%+$222.0K
Blueprint Medicines Corp047,100+47,100$0$4.36M1.10%+$4.36M
Tectonic Therapeutic, Inc.(TECX)67,461137,614+70,153$1.11M$4.17M1.06%+$3.06M
CytomX Therapeutics, Inc.(CTMX)03,022,109+3,022,109$0$3.57M0.90%+$3.57M
Sight Sciences, Inc.(SGHT)0531,222+531,222$0$3.35M0.85%+$3.35M
Viking Therapeutics, Inc.(VKTX)115,00048,000-67,000$6.10M$3.04M0.77%-$3.06M
Rocket Pharmaceuticals, Inc.(RCKT)0159,369+159,369$0$2.94M0.75%+$2.94M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)0130,000+130,000$0$2.68M0.68%+$2.68M
Mural Oncology Pub Ltd Co475,458570,620+95,162$1.49M$1.79M0.45%+$293.1K
Maravai LifeSciences Holdings, Inc.CL A(MRVI)0208,200+208,200$0$1.73M0.44%+$1.73M
Vincerx Pharma Inc2,488,4182,206,505-281,913$2.02M$1.58M0.40%-$435.8K
Rein Therapeutics Inc.(RNTX)265,000372,157+107,157$734.0K$1.32M0.33%+$583.4K
Select Med Hldgs Corp026,065+26,065$0$908.9K0.23%+$908.9K
Ovid Therapeutics Inc.(OVID)1,075,000729,208-345,792$826.9K$860.5K0.22%+$33.6K
Immunome, Inc.(IMNM)65,00039,135-25,865$786.5K$572.2K0.15%-$214.3K
Immuneering CorpCL A550,000190,000-360,000$704.0K$473.1K0.12%-$230.9K
Acadia Healthcare Company, Inc.(ACHC)05,666+5,666$0$359.3K0.09%+$359.3K
10x Genomics, Inc.CL A(TXG)49,0210-49,021$953.5K$0—-$953.5K
Addus Homecare Corp12,5000-12,500$1.45M$0—-$1.45M
Alkermes plcSHS(ALKS)275,0000-275,000$6.63M$0—-$6.63M
BioCryst Pharmaceuticals, Inc.(BCRX)398,7000-398,700$2.46M$0—-$2.46M
Biomea Fusion, Inc.(BMEA)124,3770-124,377$559.7K$0—-$559.7K
CVS Health Corporation(CVS)40,0000-40,000$2.36M$0—-$2.36M
Inspire Medical Systems, Inc.(INSP)14,0000-14,000$1.87M$0—-$1.87M
Kelly Services, Inc.CL A(KELYA)492,3400-492,340$10.54M$0—-$10.54M
Kezar Life Sciences Inc56,0800-56,080$33.6K$0—-$33.6K
LENZ Therapeutics, Inc.(LENZ)59,5420-59,542$1.03M$0—-$1.03M
Medtronic plcSHS(MDT)30,0000-30,000$2.36M$0—-$2.36M
Option Care Health, Inc.(OPCH)205,0000-205,000$5.68M$0—-$5.68M
OrthoPediatrics Corp.(KIDS)200,2160-200,216$5.76M$0—-$5.76M
Paragon 28 Inc261,4000-261,400$1.79M$0—-$1.79M
Privia Health Group, Inc.(PRVA)96,0650-96,065$1.67M$0—-$1.67M
Relay Therapeutics, Inc.(RLAY)385,0000-385,000$2.51M$0—-$2.51M
Universal Health Services, Inc.CL B(UHS)9,3730-9,373$1.73M$0—-$1.73M
Page 1 of 1
Prosight Management, LP — 13F Holdings — Q3 2024 | TickerTrail